GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,768,000 | -1.2% | 155,375 | 0.0% | 0.41% | +13.2% |
| Q4 2021 | $6,852,000 | +15.4% | 155,375 | 0.0% | 0.36% | +8.0% |
| Q3 2021 | $5,937,000 | -4.0% | 155,375 | 0.0% | 0.34% | -3.4% |
| Q2 2021 | $6,187,000 | +1.7% | 155,375 | -8.8% | 0.35% | -2.8% |
| Q1 2021 | $6,081,000 | -14.7% | 170,375 | -12.0% | 0.36% | -16.5% |
| Q4 2020 | $7,127,000 | -10.6% | 193,670 | -8.6% | 0.43% | -19.1% |
| Q3 2020 | $7,973,000 | -14.9% | 211,815 | -7.8% | 0.53% | -15.3% |
| Q2 2020 | $9,374,000 | -32.4% | 229,805 | -37.2% | 0.63% | -44.7% |
| Q1 2020 | $13,862,000 | -22.7% | 365,845 | -4.1% | 1.14% | +7.7% |
| Q4 2019 | $17,923,000 | +10.1% | 381,430 | -0.0% | 1.06% | +5.2% |
| Q3 2019 | $16,281,000 | +6.7% | 381,475 | +0.0% | 1.00% | +5.5% |
| Q2 2019 | $15,264,000 | -4.2% | 381,400 | 0.0% | 0.95% | -2.3% |
| Q1 2019 | $15,939,000 | +9.2% | 381,400 | -0.2% | 0.97% | -5.3% |
| Q4 2018 | $14,598,000 | +0.1% | 382,055 | +5.3% | 1.03% | +15.4% |
| Q3 2018 | $14,577,000 | +7.5% | 362,885 | +7.9% | 0.89% | -1.8% |
| Q2 2018 | $13,560,000 | +3.1% | 336,385 | -0.1% | 0.91% | -1.0% |
| Q1 2018 | $13,153,000 | +10.8% | 336,645 | +0.6% | 0.92% | +9.0% |
| Q4 2017 | $11,868,000 | -12.4% | 334,600 | +0.3% | 0.84% | -15.7% |
| Q3 2017 | $13,548,000 | +0.9% | 333,695 | +7.2% | 1.00% | -1.3% |
| Q2 2017 | $13,423,000 | +12.5% | 311,300 | +10.0% | 1.01% | +6.1% |
| Q1 2017 | $11,935,000 | +74.6% | 283,080 | +59.5% | 0.95% | +41.4% |
| Q4 2016 | $6,836,000 | +149.8% | 177,500 | +159.5% | 0.67% | +139.0% |
| Q3 2016 | $2,737,000 | -7.7% | 68,400 | 0.0% | 0.28% | -20.8% |
| Q2 2016 | $2,964,000 | +6.8% | 68,400 | 0.0% | 0.36% | +4.7% |
| Q1 2016 | $2,774,000 | +0.5% | 68,400 | 0.0% | 0.34% | +3.3% |
| Q4 2015 | $2,760,000 | +19.0% | 68,400 | +13.4% | 0.33% | +7.2% |
| Q3 2015 | $2,319,000 | +22.1% | 60,300 | +32.2% | 0.31% | +32.9% |
| Q2 2015 | $1,899,000 | +8.9% | 45,600 | +20.6% | 0.23% | +10.0% |
| Q1 2015 | $1,744,000 | +7.9% | 37,800 | 0.0% | 0.21% | +8.8% |
| Q4 2014 | $1,616,000 | -7.0% | 37,800 | 0.0% | 0.19% | -9.8% |
| Q3 2014 | $1,738,000 | -14.0% | 37,800 | 0.0% | 0.21% | -13.4% |
| Q2 2014 | $2,022,000 | +0.1% | 37,800 | 0.0% | 0.25% | -1.2% |
| Q1 2014 | $2,020,000 | +0.1% | 37,800 | 0.0% | 0.25% | +14.7% |
| Q4 2013 | $2,018,000 | +3.3% | 37,800 | -3.3% | 0.22% | -6.4% |
| Q2 2013 | $1,954,000 | – | 39,100 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |